MTL1 Leucoflex

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: MTL1 Leucoflex
Generic name: ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION WITH AS-1
Manufacturer: Maco Productions
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 0a0b25d1-8fa1-6cd4-e054-00144ff8d46c
SPL ID: 18eb3182-4153-4c8e-96e7-a4f30a8557c4
Version: 15
Effective date: 2025-12-29
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:18:53

Harmonized routes table
Harmonized routes
INTRAVENOUS

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		BN040083	openfda.application_number
brand name		MTL1 Leucoflex	openfda.brand_name
generic name		ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION WITH AS-1	openfda.generic_name
manufacturer name		Maco Productions	openfda.manufacturer_name
ndc	package	14498-001-01	openfda.package_ndc
ndc	product	14498-001	openfda.product_ndc
ndc11	package	14498000101	derived:openfda.package_ndc
spl id		18eb3182-4153-4c8e-96e7-a4f30a8557c4	id
spl set id		0a0b25d1-8fa1-6cd4-e054-00144ff8d46c	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNING Avoid contact with sharp objects. DO NOT USE if the overwrap or blood bag system shows any signs of deterioration. DO NOT USE if the solutions are not clear. Dispose of all system components that have been contaminated with blood in a biohazard container as per your institution's SOP. Dispose of all sharps as per your institution's SOP.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.